Your session is about to expire
← Back to Search
Procedure
Total Laparoscopic or Robotic Radical Hysterectomy for Cervical Cancer (LACC Trial)
N/A
Waitlist Available
Research Sponsored by Queensland Centre for Gynaecological Cancer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with Histologically confirmed stage IA1 (with lymph vascular invasion), stage IA2, or stage IB1 disease
Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma of the uterine cervix;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years from surgery
Awards & highlights
LACC Trial Summary
This trial is comparing two types of surgery for cervical cancer, to see which one has better long-term outcomes.
Eligible Conditions
- Cervical Cancer
LACC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLACC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years from surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years from surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disease free survival
Secondary outcome measures
Costs
Feasibility of sentinel lymph node biopsy
Intra-operative, peri-operative, post-operative and long term treatment related morbidity
+4 moreLACC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Total Laparoscopic or Robotic Radical Hysterectomy
Group II: 1Active Control1 Intervention
Total Abdominal Radical Hysterectomy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Total Laparoscopic or Robotic Radical Hysterectomy
2008
N/A
~640
Find a Location
Who is running the clinical trial?
Queensland Centre for Gynaecological CancerLead Sponsor
15 Previous Clinical Trials
4,249 Total Patients Enrolled
M.D. Anderson Cancer CenterOTHER
2,958 Previous Clinical Trials
1,797,813 Total Patients Enrolled
Andreas Obermair, MDStudy ChairQueensland Centre for Gynecological Cancer
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger